7 Morley, L.C., et al., Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Attachment style and post-bariatric surgery health behaviours: the mediating role of self-esteem and health self-efficacy
IR promotes hepatic steatosis and increases ROS levels by causing hyperglycemia and hyperinsulinemia due to reduced mitochondrial beta-oxidation
The initial dosing protocol starts with tirzepatide 2.5 mg weekly plus cagrilintide 0.3 mg weekly, with gradual escalation over several weeks to minimize side effects
Wharton S, Batterham RL, Bhatta M, et al
Role of GABAergic antagonism in the neuroprotective effects of bilobalide